Omission of axillary lymph node dissection in cN2-3 breast cancer patients with an excellent response on primary systemic treatment is safe: 4-year oncologic outcome of the MARI protocol

A. van Hemert,A.A. van Loevezijn, M.S.P.D. Baas, M.P.M. Stokkel, E. Groen, C. Loo, V. van der Noort, G.S. Sonke, N.S. Russell,F.H. van Duijnhoven, M.J.T.F.D. Vrancken Peeters

European Journal of Cancer（2024）

引用 0|浏览0